View in EDS HTML Full Text PDF Full Text

Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer.

Saved in:
Bibliographic Details
Title: Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer.
Authors: Takahashi, Ken1,2 (AUTHOR), Seto, Yosuke1 (AUTHOR), Okada, Koutaroh1 (AUTHOR), Uematsu, Shinya3 (AUTHOR), Uchibori, Ken3 (AUTHOR), Tsukahara, Mika1 (AUTHOR), Oh‐hara, Tomoko1 (AUTHOR), Fujita, Naoya4 (AUTHOR), Yanagitani, Noriko3 (AUTHOR), Nishio, Makoto3 (AUTHOR), Okubo, Kenichi2 (AUTHOR), Katayama, Ryohei1 (AUTHOR) ryohei.katayama@jfcr.or.jp
Source: Thoracic Cancer. Mar2020, Vol. 11 Issue 3, p581-587. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17597706
DOI:10.1111/1759-7714.13299